СЛУЧАЙ CMV МЕНИНГОЕНЦЕФАЛИТА У ПАЦИЕНТКИ, ПОЛУЧАЮЩЕЙ ЦИТОСТАТИКИ
Аннотация
Резюме. В статье описан случай CMV менингоэнцефалита у пациентки, получающей цитостатические препараты по поводу ревматоидного артрита. Учитывая сложность диагностики данного случая цитомегаловирусной инфекции, ее широкое распространение в популяции и возможные многосторонние проявления заболевания от бессимптомного течения до тяжелых генерализованных форм, авторами выполнен литературный обзор этой проблемы в помощь практикующему врачу.
Литература
1. Akhter K., Cytomegalovirus Medscape / K. Akhter / Updated. – 2011. – Aug 17
2. Benjamin L.A. Detection of herpes viruses in the cerebrospinal fluid of adults with suspected viral meningitis in Malawi / LA. Benjamin, V. Kelly, D. Cohen, F. Neuhann et al // Infection. – 2013. – 411). – Р. 27-31
3. Boeckh M. Complications, Diagnosis, Management, and Prevention of CMV Infections: Current and Future / M. Boeckh // ASH Education Book. – 2011. – № 1. – Р. 305-309
4. Britt W. Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease / W. Britt // Curr Top Microbiol Immunol. – 2008. – 325. – Р. 417-470
5. Calvario A. Herpes Consensus PCR test: a useful diagnostic approach to the screening of viral diseases of the central nervous system / A . Calvario, A . Bozzi, M. Scarasciulli, C . Ventola et al. // J. Clin Virol. – 2002. – 25 Suppl 1. – Р. 71-78
6. Cannon M.J. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection / M.J. Cannon, D.S. Schmid, T.B. Hyde // Rev Med Virol. – 2010. – 20 (4). – Р. 202-13
7. Cohen J.I. Cytomegalovirus infection in the normal host / J.I. Cohen, G.R. Corey // Medicine (Baltimore). – 1985. – 64 (2). – Р. 100-114
8. Collier A.C. Cytomegalovirus infection in homosexual men. Relationship to sexual practices, antibody to human immunodeficiency virus, and cell-mediated immunity / A.C. Collier, J.D. Meyers, L. Corey // Am. J. Med. – 1987. – 82 (3 Spec No). – Р. 593-601
9. Dzabic M. High prevalence of an active cytomegalovirus infection in the appendix of immunocompetent patients with acute appendicitis / M. Dzabic, L . Boström, A . Rahbar // Inflamm Bowel Dis. – 2008. – 14 (2). – Р. 236-241
10. Florescu D.F. Cytomegalovirus infections in non-immunocompromised and immunocompromised patients in the intensive care unit / D.F. Florescu, A.C. Kalil. // Infect. Disord. Drug Targets. – 2011. – 11 (4). – Р. 354-64
11. Fujiwara S. Intrathecal administration of high-titer cytomegalovirus immunoglobulin for cytomegalovirus meningitis / S. Fujiwara, K. Muroi, R. Tatara, K. Ohmine et al. // Case Rep Hematol. – 2014. – 2014. – Р. 272458
12. Gaj Z. Seroprevalence of cytomegalovirus infection in the population of Polish pregnant women / Z. Gaj, M. Rycel, J. Wilczyński, D. Nowakowska // Ginekol Pol. – 2012. – 83 (5). – Р. 337-341
13. Gallamini A. Alemtuzumab (Campath-1H) and CHOP chemotherapy as fi rst-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial / A. Gallamini, F. Zaja, C. Patti // Blood. – 2007. – 110. – Р. 2316–23
14. Gupta P. Risk factors for chronic rejection after pediatric liver transplantation / P. Gupta, J. Hart, D. Cronin, S. Kelly, J.M. Millis, L. Brady // Transplantation. – 2001. – 72. – Р. 1098-1102
15. Hamer M. Obesity, Metabolic Health, and History of Cytomegalovirus Infection in the General Population / M. Hamer, G.D. Batty, M. Kivimäki // J. Clin Endocrinol Metab. – 2016. – Feb 10: jc20154208
16. Heininger A. Human cytomegalovirus infections in nonimmunosuppressed critically ill patients / A. Heininger, G. Jahn, C. Engel, T. Notheisen, K. Unertl, K. Hamprecht // Crit Care Med. – 2001. – 29 (3). – Р. 541-7
17. Hubel K. Suppressed neutrophil function as a risk factor for severe infection after cytotoxic chemotherapy in patients with acute nonlymphocytic leukemia / K. Hubel, K. Hegener, R. Schnell // Ann. Hematol. – 1999. – 78. – Р. 73-77
18. Jong de M.D. Summary of the II International Symposium on Cytomegalovirus / M.D. de Jong, G.J. Galasso, B. Gazzard, P.D. Griffiths, D.A. Jabs, E.R. Kern, S.A. Spector // Antiviral Res. – 1998. – 39. – Р. 141-162
19. Khalafkhany D. Prevalence and genotype distribution of cytomegalovirus UL55 sequence in renal transplant recipients in north west of Iran / D. Khalafkhany, K. Makhdoomi, A.T. Afshari, M. Motazakker // J Med Virol. 2016 Mar 4. doi: 10.1002 / jmv. 24509
20. Korndewal M.J. Cytomegalovirus infection in the Netherlands: seroprevalence, risk factors, and implications / M.J. Korndewal, L. Mollema, I. Tcherniaeva, F. van der Klis, A.C. Kroes, A.M. Oudesluys-Murphy, A.C. Vossen, H.E. de Melker // J. Clin Virol. – 2015. – 63. – Р. 53-58
21. Ljungman P. Definitions of cytomegalovirus infection and disease in transplant recipients / P. Ljungman, P. Griffiths, C. Paya // Clin Infect Dis. Apr. – 2002. – 34 (8). – Р. 1094–7
22. Mekker A. Immune senescence: relative contributions of age and cytomegalovirus infection / A. Mekker, V.S. Tchang, L. Haeberli, A. Oxenius, A. Trkola, U. Karrer // PLoS Pathog. – 2012. – 8 (8): e1002850. doi: 10.1371 / journal. ppat. 1002850
23. Mustakangas P. Human cytomegalovirus seroprevalence in three socioeconomically different urban areas during the first trimester: a population-based cohort study / P. Mustakangas, S. Sarna, P. Ammälä, M. Muttilainen, P. Koskela, M. Koskiniemi // Int J. Epidemiol. – 2000. – 29 (3). – Р. 587-91
24. Nguyen D.D. Cytomegalovirus viremia during Campath-1H therapy for relapsed and refractory chronic lymphocytic leukemia and prolymphocytic leukemia / D.D. Nguyen, T.M. Cao, K. Dugan // Clin. Lymphoma. – 2002. – 3. – Р. 105-10
25. Nquyen Q. Cytomegalovirus pneumonia in adults with leukemia: an emerging problem / Q. Nquyen, E. Estey, I.Raad // Clin. Infect. Dis. – 2001. – 32. – Р. 539-45
26. Ory de F. Viral infections of the central nervous system in Spain: a prospective study / F. de Ory, A. Avellón, J.E. Echevarría, M.P. Sánchez-Seco et al. // J. Med Virol. – 2013. – 85 (3). – Р. 554-62
27. Pembrey L. Seroprevalence of cytomegalovirus, Epstein Barr virus and varicella zoster virus among pregnant women in Bradford: a cohort study / L. Pembrey, P. Raynor, P. Griffiths, S. Chaytor, J. Wright, A.J. Hall // PLoS One. 2013;8: e81881
28. Peters M. Combined and alternating ganciclovir and foscarnet in acute and maintenance therapy of human immunodeficiency virus-related cytomegalovirus encephalitis refractory to ganciclovir alone. A case report and review of the literature / M. Peters, U. Timm, D. Schürmann, H.D. Pohle, B. Ruf // Clin Investig. – 1992. 70 (5). – Р. 456-8
29. Ponticelli C. Neurological complications in kidney transplant recipients / C. Ponticelli, M.R. Campise // J. Nephrol. – 2005. – 18 (5). – Р. 521-8
30. Price T.A. Ganciclovir treatment of cytomegalovirus ventriculitis in a patient infected with human immunodeficiency virus / T.A. Price, R.A. Digioia, G.L. Simon // Clin Infect Dis. – 1992. – 15 (4). – Р. 606-8
31. Pruitt A.A. Central nervous system infections in cancer patients / A.A. Pruitt // Neurol Clin. – 1991. – 9 (4) – Р. 867-88
32. Rafailidis P.I. Cytomegalovirus meningitis in an immunocompetent patient / P.I. R afailidis, A . Kapaskelis, M.E. Falagas. // Med Sci Monit. – 2007. – 13 (9). – Р. 107-109
33. Reinhard B. Rapid quantitation of cytomegalovirus DNA in whole blood by a new molecular assay based on automated sample preparation and real-time PCR / B. Reinhard // Medical Microbiology and Immunology. – 2010. – Vol. 199, № 4. – Р. 311-316
34. Reuter J.D. Systemic immune deficiency necessary for cytomegalovirus invasion of the mature brain / J.D. Reuter, D.L. Gomez, J.H. Wilson, A.N. Van Den Pol // J. Virol. – 2004. – 78 (3). – Р. 1473-87
35. Römkens T.E. Cytomegalovirus in inflammatory bowel disease: A systematic review / T.E. Römkens, G.J. Bulte, L.H. Nissen, J.P. Drenth // World J. Gastroenterol. – 2016. – 22 (3). – Р. 1321–1330
36. Siennicka J. C entral n ervous s ystem v iral i nfectionsanalysis of routine laboratory results / J . Siennicka, A . Trzcińska // Med Dosw Mikrobiol. – 2008. – 60 (3). – Р. 253-8
37. Stals F.S. Combinations of ganciclovir and antibody for experimental CMVinfections / F.S. Stals, S.S. Wagenaar, J.S. Kloover, W.Y. Vanagt, C.A. Bruggeman // Antiviral Res. – 1996. – 29 (1). – Р. 61-4
38. Vivolo M. Prevalence of cytomegalovirus infection in pediatric patients with neurological disorders in Zulia state, Venezuela (2007–2008) / M. Vivolo, A. Durán, L.Atacho, L. Porto, J. Bermúdez, N. Valero // Invest Clin. – 2012. – 53 (2). – Р. 178-89
39. Voigt S. Cytomegalovirus Seroprevalence Among Children and Adolescents in Germany: Data From the German Health Interview and Examination Survey for Children and Adolescents (KiGGS), 2003–2006. / S. Voigt, A. Schaffrath Rosario, A. Mankertz // Open Forum Infect Dis. – 2015. Dec 9; 3 (1): ofv193. doi: 10.1093/ofid/ofv193
40. Watzinger F. Detection and monitoring of virus infections by real-time PCR / F. Watzinger, K. Ebner // Mol Aspects Med. – 2006. – 27 (2–3). – Р. 254-98
41. Yerly S. Cytomegalovirus quantification in plasma by an automated real-time PCR assay / S. Yerly // Journal of Clinical Virology. – 2007. – Vol. 38, Issue 4. – Р. 298-303
2. Benjamin L.A. Detection of herpes viruses in the cerebrospinal fluid of adults with suspected viral meningitis in Malawi / LA. Benjamin, V. Kelly, D. Cohen, F. Neuhann et al // Infection. – 2013. – 411). – Р. 27-31
3. Boeckh M. Complications, Diagnosis, Management, and Prevention of CMV Infections: Current and Future / M. Boeckh // ASH Education Book. – 2011. – № 1. – Р. 305-309
4. Britt W. Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease / W. Britt // Curr Top Microbiol Immunol. – 2008. – 325. – Р. 417-470
5. Calvario A. Herpes Consensus PCR test: a useful diagnostic approach to the screening of viral diseases of the central nervous system / A . Calvario, A . Bozzi, M. Scarasciulli, C . Ventola et al. // J. Clin Virol. – 2002. – 25 Suppl 1. – Р. 71-78
6. Cannon M.J. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection / M.J. Cannon, D.S. Schmid, T.B. Hyde // Rev Med Virol. – 2010. – 20 (4). – Р. 202-13
7. Cohen J.I. Cytomegalovirus infection in the normal host / J.I. Cohen, G.R. Corey // Medicine (Baltimore). – 1985. – 64 (2). – Р. 100-114
8. Collier A.C. Cytomegalovirus infection in homosexual men. Relationship to sexual practices, antibody to human immunodeficiency virus, and cell-mediated immunity / A.C. Collier, J.D. Meyers, L. Corey // Am. J. Med. – 1987. – 82 (3 Spec No). – Р. 593-601
9. Dzabic M. High prevalence of an active cytomegalovirus infection in the appendix of immunocompetent patients with acute appendicitis / M. Dzabic, L . Boström, A . Rahbar // Inflamm Bowel Dis. – 2008. – 14 (2). – Р. 236-241
10. Florescu D.F. Cytomegalovirus infections in non-immunocompromised and immunocompromised patients in the intensive care unit / D.F. Florescu, A.C. Kalil. // Infect. Disord. Drug Targets. – 2011. – 11 (4). – Р. 354-64
11. Fujiwara S. Intrathecal administration of high-titer cytomegalovirus immunoglobulin for cytomegalovirus meningitis / S. Fujiwara, K. Muroi, R. Tatara, K. Ohmine et al. // Case Rep Hematol. – 2014. – 2014. – Р. 272458
12. Gaj Z. Seroprevalence of cytomegalovirus infection in the population of Polish pregnant women / Z. Gaj, M. Rycel, J. Wilczyński, D. Nowakowska // Ginekol Pol. – 2012. – 83 (5). – Р. 337-341
13. Gallamini A. Alemtuzumab (Campath-1H) and CHOP chemotherapy as fi rst-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial / A. Gallamini, F. Zaja, C. Patti // Blood. – 2007. – 110. – Р. 2316–23
14. Gupta P. Risk factors for chronic rejection after pediatric liver transplantation / P. Gupta, J. Hart, D. Cronin, S. Kelly, J.M. Millis, L. Brady // Transplantation. – 2001. – 72. – Р. 1098-1102
15. Hamer M. Obesity, Metabolic Health, and History of Cytomegalovirus Infection in the General Population / M. Hamer, G.D. Batty, M. Kivimäki // J. Clin Endocrinol Metab. – 2016. – Feb 10: jc20154208
16. Heininger A. Human cytomegalovirus infections in nonimmunosuppressed critically ill patients / A. Heininger, G. Jahn, C. Engel, T. Notheisen, K. Unertl, K. Hamprecht // Crit Care Med. – 2001. – 29 (3). – Р. 541-7
17. Hubel K. Suppressed neutrophil function as a risk factor for severe infection after cytotoxic chemotherapy in patients with acute nonlymphocytic leukemia / K. Hubel, K. Hegener, R. Schnell // Ann. Hematol. – 1999. – 78. – Р. 73-77
18. Jong de M.D. Summary of the II International Symposium on Cytomegalovirus / M.D. de Jong, G.J. Galasso, B. Gazzard, P.D. Griffiths, D.A. Jabs, E.R. Kern, S.A. Spector // Antiviral Res. – 1998. – 39. – Р. 141-162
19. Khalafkhany D. Prevalence and genotype distribution of cytomegalovirus UL55 sequence in renal transplant recipients in north west of Iran / D. Khalafkhany, K. Makhdoomi, A.T. Afshari, M. Motazakker // J Med Virol. 2016 Mar 4. doi: 10.1002 / jmv. 24509
20. Korndewal M.J. Cytomegalovirus infection in the Netherlands: seroprevalence, risk factors, and implications / M.J. Korndewal, L. Mollema, I. Tcherniaeva, F. van der Klis, A.C. Kroes, A.M. Oudesluys-Murphy, A.C. Vossen, H.E. de Melker // J. Clin Virol. – 2015. – 63. – Р. 53-58
21. Ljungman P. Definitions of cytomegalovirus infection and disease in transplant recipients / P. Ljungman, P. Griffiths, C. Paya // Clin Infect Dis. Apr. – 2002. – 34 (8). – Р. 1094–7
22. Mekker A. Immune senescence: relative contributions of age and cytomegalovirus infection / A. Mekker, V.S. Tchang, L. Haeberli, A. Oxenius, A. Trkola, U. Karrer // PLoS Pathog. – 2012. – 8 (8): e1002850. doi: 10.1371 / journal. ppat. 1002850
23. Mustakangas P. Human cytomegalovirus seroprevalence in three socioeconomically different urban areas during the first trimester: a population-based cohort study / P. Mustakangas, S. Sarna, P. Ammälä, M. Muttilainen, P. Koskela, M. Koskiniemi // Int J. Epidemiol. – 2000. – 29 (3). – Р. 587-91
24. Nguyen D.D. Cytomegalovirus viremia during Campath-1H therapy for relapsed and refractory chronic lymphocytic leukemia and prolymphocytic leukemia / D.D. Nguyen, T.M. Cao, K. Dugan // Clin. Lymphoma. – 2002. – 3. – Р. 105-10
25. Nquyen Q. Cytomegalovirus pneumonia in adults with leukemia: an emerging problem / Q. Nquyen, E. Estey, I.Raad // Clin. Infect. Dis. – 2001. – 32. – Р. 539-45
26. Ory de F. Viral infections of the central nervous system in Spain: a prospective study / F. de Ory, A. Avellón, J.E. Echevarría, M.P. Sánchez-Seco et al. // J. Med Virol. – 2013. – 85 (3). – Р. 554-62
27. Pembrey L. Seroprevalence of cytomegalovirus, Epstein Barr virus and varicella zoster virus among pregnant women in Bradford: a cohort study / L. Pembrey, P. Raynor, P. Griffiths, S. Chaytor, J. Wright, A.J. Hall // PLoS One. 2013;8: e81881
28. Peters M. Combined and alternating ganciclovir and foscarnet in acute and maintenance therapy of human immunodeficiency virus-related cytomegalovirus encephalitis refractory to ganciclovir alone. A case report and review of the literature / M. Peters, U. Timm, D. Schürmann, H.D. Pohle, B. Ruf // Clin Investig. – 1992. 70 (5). – Р. 456-8
29. Ponticelli C. Neurological complications in kidney transplant recipients / C. Ponticelli, M.R. Campise // J. Nephrol. – 2005. – 18 (5). – Р. 521-8
30. Price T.A. Ganciclovir treatment of cytomegalovirus ventriculitis in a patient infected with human immunodeficiency virus / T.A. Price, R.A. Digioia, G.L. Simon // Clin Infect Dis. – 1992. – 15 (4). – Р. 606-8
31. Pruitt A.A. Central nervous system infections in cancer patients / A.A. Pruitt // Neurol Clin. – 1991. – 9 (4) – Р. 867-88
32. Rafailidis P.I. Cytomegalovirus meningitis in an immunocompetent patient / P.I. R afailidis, A . Kapaskelis, M.E. Falagas. // Med Sci Monit. – 2007. – 13 (9). – Р. 107-109
33. Reinhard B. Rapid quantitation of cytomegalovirus DNA in whole blood by a new molecular assay based on automated sample preparation and real-time PCR / B. Reinhard // Medical Microbiology and Immunology. – 2010. – Vol. 199, № 4. – Р. 311-316
34. Reuter J.D. Systemic immune deficiency necessary for cytomegalovirus invasion of the mature brain / J.D. Reuter, D.L. Gomez, J.H. Wilson, A.N. Van Den Pol // J. Virol. – 2004. – 78 (3). – Р. 1473-87
35. Römkens T.E. Cytomegalovirus in inflammatory bowel disease: A systematic review / T.E. Römkens, G.J. Bulte, L.H. Nissen, J.P. Drenth // World J. Gastroenterol. – 2016. – 22 (3). – Р. 1321–1330
36. Siennicka J. C entral n ervous s ystem v iral i nfectionsanalysis of routine laboratory results / J . Siennicka, A . Trzcińska // Med Dosw Mikrobiol. – 2008. – 60 (3). – Р. 253-8
37. Stals F.S. Combinations of ganciclovir and antibody for experimental CMVinfections / F.S. Stals, S.S. Wagenaar, J.S. Kloover, W.Y. Vanagt, C.A. Bruggeman // Antiviral Res. – 1996. – 29 (1). – Р. 61-4
38. Vivolo M. Prevalence of cytomegalovirus infection in pediatric patients with neurological disorders in Zulia state, Venezuela (2007–2008) / M. Vivolo, A. Durán, L.Atacho, L. Porto, J. Bermúdez, N. Valero // Invest Clin. – 2012. – 53 (2). – Р. 178-89
39. Voigt S. Cytomegalovirus Seroprevalence Among Children and Adolescents in Germany: Data From the German Health Interview and Examination Survey for Children and Adolescents (KiGGS), 2003–2006. / S. Voigt, A. Schaffrath Rosario, A. Mankertz // Open Forum Infect Dis. – 2015. Dec 9; 3 (1): ofv193. doi: 10.1093/ofid/ofv193
40. Watzinger F. Detection and monitoring of virus infections by real-time PCR / F. Watzinger, K. Ebner // Mol Aspects Med. – 2006. – 27 (2–3). – Р. 254-98
41. Yerly S. Cytomegalovirus quantification in plasma by an automated real-time PCR assay / S. Yerly // Journal of Clinical Virology. – 2007. – Vol. 38, Issue 4. – Р. 298-303
Опубликована
2017-09-28
Как цитировать
ЧЕБАЛИНА, Е. А.; САЛОНИКИДИ, А. И.; ЖИДКИХ, В. Н..
СЛУЧАЙ CMV МЕНИНГОЕНЦЕФАЛИТА У ПАЦИЕНТКИ, ПОЛУЧАЮЩЕЙ ЦИТОСТАТИКИ.
Университетская клиника, [S.l.], v. 12, n. 2, p. 101 - 105, сен. 2017.
ISSN 1819-0464. Доступно на: <http://journal.dnmu.ru/index.php/UC/article/view/40>. Дата доступа: 22 ноя. 2024
Раздел
В помощь практикующему врачу
